Analyst Reco. Cardlytics, Inc.

Equities

CDLX

US14161W1053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
9.4 ^USD	+7.18%		+6.94%	+2.06%

May. 23	Cardlytics, Inc. Approves Deloitte & Touche LLP as Independent Registered Public Accounting Firm	CI
May. 09	Craig-Hallum Adjusts Cardlytics Price Target to $12 From $18, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Craig-Hallum Adjusts Cardlytics Price Target to $12 From $18, Maintains Buy Rating	May. 09	MT
Needham Adjusts Price Target on Cardlytics to $12 From $17, Keeps Buy Rating	May. 09	MT
Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing	Apr. 25	MT
Needham Raises Cardlytics' Price Target to $17 From $15, Maintains Buy Rating	Apr. 09	MT
Cardlytics Insider Sold Shares Worth $448,020, According to a Recent SEC Filing	Apr. 03	MT
Craig-Hallum Upgrades Cardlytics to Buy From Hold, Adjusts Price Target to $18 From $10	Mar. 15	MT
Lake Street Adjusts Cardlytics' Price Target to $18 From $13, Maintains Buy Rating	Mar. 15	MT
Lake Street Starts Coverage on Cardlytics with Buy Rating, $13 Price Target	Nov. 29	MT
Needham Adjusts Price Target on Cardlytics to $19 From $10, Maintains Buy Rating	23-08-02	MT
Needham Adjusts Price Target on Cardlytics to $10 From $8, Maintains Buy Rating	23-05-05	MT
Wells Fargo Adjusts Price Target on Cardlytics to $6 From $5, Keeps Underweight Rating	23-04-12	MT
JPMorgan Adjusts Cardlytics Price Target to $6 From $7, Maintains Neutral Rating	23-03-02	MT
Wells Fargo Adjusts Price Target on Cardlytics to $5 From $6, Keeps Underweight Rating	23-03-02	MT
Needham Lowers Price Target on Cardlytics to $8 From $14, Maintains Buy Rating	23-03-02	MT
Wells Fargo Adjusts Price Target on Cardlytics to $6 From $10, Maintains Underweight Rating	23-01-09	MT
Needham Adjusts Price Target on Cardlytics to $14 From $19, Maintains Buy Rating	22-11-02	MT
Wells Fargo Adjusts Cardlytics Price Target to $10 From $13, Maintains Underweight Rating	22-11-02	MT
Wells Fargo Downgrades Cardlytics to Underweight From Equalweight, Trims Price Target to $13 From $14	22-09-08	MT
Wells Fargo Trims Cardlytics Price Target to $14 From $15, Maintains Equalweight Rating	22-08-03	MT
Needham Adjusts Cardlytics' Price Target to $19 From $24, Reiterates Buy Rating	22-08-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cardlytics, Inc.

Equities

CDLX

US14161W1053

Analyst Reco.

Filters